Sign up
Quantellect · Congress · Congressional Trade

Ro Khanna bought Edwards Lifesciences Corp (NYSE: EW)

Ro Khanna bought Edwards Lifesciences Corp (EW), disclosed February 6, 2026

Ro Khanna bought EW · disclosed February 6, 2026

Ro Khanna, a CA House member representing District 17, purchased $1,001 - $15,000 of Edwards Lifesciences Corp (EW) on January 29, 2026. Filings associated with Ro Khanna disclosed 4 other EW transactions (1 purchase and 3 sales) in the 12 months before this trade. Shares of EW have risen 130.1% since the first observed purchase on September 7, 2017. The filing was publicly disclosed on February 6, 2026; a direct filing link is not available in the current data record.

Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For Ro Khanna's complete filing history, visit Ro Khanna's full trade history. Browse all trading members of Congress tracked by Quantellect.

Key points

  • Analyst ratings on EW break down as 0 strong buy, 15 buy, 5 hold, 0 sell, 0 strong sell.
  • EW carries a Risk Score of 95 as of September 9, 2026. On this scale, a higher score means a lower risk surface.
  • Ro Khanna bought EW in the amount range of $1,001 - $15,000 on January 29, 2026, filed under the STOCK Act.
  • The filing lists Spouse as the transaction owner and was disclosed 8 days after the trade.
  • The asset description in the filing reads 'EDWARDS LIFESCIENCES CORPORATI (CMN).'
  • Filings associated with Ro Khanna disclosed 4 other EW transactions (1 purchase and 3 sales) in the 12 months before this trade.
  • Shares of EW have risen 130.1% since the first observed purchase on September 7, 2017.
  • EW carried a Q Score of 56.4 in its equity peer group as of September 8, 2026.
  • EW carried a Squeeze Score of 16 as of September 10, 2026.

Did Ro Khanna buy or sell EW?

The Periodic Transaction Report covers a single purchase involving EW on January 29, 2026. The filed amount range is $1,001 - $15,000. The asset description reads 'EDWARDS LIFESCIENCES CORPORATI (CMN)', as submitted by the filer. The report was submitted on February 6, 2026. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.

PoliticianActionTickerAmountTrade dateFiled
Ro Khanna (House)BuyEW$1,001 - $15,000January 29, 2026February 6, 2026

What other EW trades has Ro Khanna disclosed in the past 12 months?

Filings associated with Ro Khanna disclosed 4 other EW transactions (1 purchase and 3 sales) in the 12 months before this trade.

Trade dateActionOwnerAmountFiling
January 23, 2026SellDependent child$1,001 - $15,000Filing unavailable
January 13, 2026SellSpouse$1,001 - $15,000Filing unavailable
October 7, 2025SellSpouse$1,001 - $15,000Filing unavailable
March 12, 2025BuySpouse$1,001 - $15,000Filing unavailable

What does the filing show, and what does it not show?

The filing reports a purchase involving EW by Ro Khanna in the amount range of $1,001 - $15,000, with Spouse listed as the owner. It does not establish Ro Khanna's total holdings in EW, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'EDWARDS LIFESCIENCES CORPORATI (CMN)', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify Ro Khanna's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with Ro Khanna disclosed 4 other EW transactions (1 purchase and 3 sales) in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.

Who else in Congress traded EW?

Quantellect's current database lists these recent EW disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.

MemberPartyActionAmountDisclosed
Alan Armstrong SelfR SenateBuy$1,001 - $15,000July 21, 2026Filing unavailable
Josh Gottheimer JointD HouseSell$1,001 - $15,000December 29, 2025Filing unavailable

How has Ro Khanna's disclosed trading performed?

Ro Khanna holds a Quantellect Q Score of 90 (elite), a descriptive rating of disclosed congressional buys over the trailing 24 months, based on estimated, unrealized results from filed amount ranges and closing prices.

Q Score rank #9 of 77 rated members. The rating covers buys only: entry uses the transaction-date close, positions are marked to the latest close, and dollar figures are estimates from the disclosed ranges, not realized gains. It describes disclosed activity and is not investment advice.

All Ro Khanna EW trades

TradedTypeSizeReturnEst. profit
August 3, 2026Sell$1,001 - $15,000-2.97%
May 27, 2026Buy$1,001 - $15,000-0.38%-$31
May 15, 2026Buy$1,001 - $15,000+5.90%+$472
May 1, 2026Buy$1,001 - $15,000+2.62%+$210
April 24, 2026Sell$1,001 - $15,000+2.41%
April 13, 2026Buy$1,001 - $15,000+10.32%+$825
March 30, 2026Sell$1,001 - $15,000+8.40%
March 23, 2026Buy$1,001 - $15,000+5.07%+$406
February 5, 2026Sell$1,001 - $15,000+10.35%
January 29, 2026Buy$1,001 - $15,000+5.76%+$460

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Frequently asked questions

Did Ro Khanna buy or sell EW?

According to the disclosure, Ro Khanna purchased EW on January 29, 2026.

What amount was reported for the EW transaction?

The disclosure reports $1,001 - $15,000 for the purchase. Filed amounts are ranges, not exact transaction values.

When did the transaction occur, and when was it disclosed?

The transaction is dated January 29, 2026, and it was disclosed on February 6, 2026.

Where can I see Ro Khanna's other congressional trades?

Quantellect lists Ro Khanna's complete disclosed trade history on the member profile. Ro Khanna's trade history

Is congressional stock trading legal?

The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act

Is Congress exempt from insider trading laws?

No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act

How quickly must members of Congress disclose a trade?

Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance

How is net worth reported in these disclosures?

It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act

Like this article? Share it
Methodology & disclaimer. Trades reflect Periodic Transaction Reports filed under the STOCK Act of 2012, which requires members of Congress to disclose covered transactions, generally within 30 days of receiving notice of the transaction and no later than 45 days after the transaction; disclosed amounts are the broad ranges in the official filing, not exact figures. Estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended. The Q Score measures a member's disclosed-trade track record against a sector-matched benchmark. This article is generated programmatically for education and research only. It is not investment advice, a recommendation, or an allegation of unlawful trading.

Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.